T3	Effect 42 61	ocular hypertension
T4	Subject 65 78	four patients
T5	Treatment 102 113	ranibizumab
T7	Population 65 69	four
T8	Drug 102 113	ranibizumab
T6	Adverse_event 28 38	occurrence
E1	Adverse_event:T6